Mazzariello Gina
Transaction: 07/10/2026
SELL
Change
-15,000
Price
$17.61
Filing
07/13/2026
Type
SELL
Amylyx Pharmaceuticals, Inc.
AMLX • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$2.69B
Growth
-100.0%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 95.9%Manageable debt level · 0.02Healthy liquidity · 14.27Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$2.69B
52W Range7.48 - 24.36
Beta-0.20
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio14.27
Quick Ratio14.27
Revenue 5Y-100.00%
Price$0.00
Change0.00%
Market Cap$2.69B
52W Range7.48 - 24.36
Beta-0.20
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio14.27
Quick Ratio14.27
Revenue 5Y-100.00%
Target$32.67
Target Median$34.00
Target Range24.00 - 40.00
Volume3.36M
Avg Volume1.43M
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
55
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score▼
Positive revenue growth · 95.9%Manageable debt level · 0.02Healthy liquidity · 14.27Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$24.00
Mean
$32.67
Median
$34.00
High
$40.00
Insider Transactions
Recent executive and insider activity
Mazzariello Gina
Transaction: 07/09/2026
SELL
Change
-15,000
Price
$18.32
Filing
07/13/2026
Type
SELL
FONTEYNE PAUL R.
Transaction: 06/04/2026
BUY
Change
+24,372
Price
$14.31
Filing
06/08/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mazzariello Gina | SELL | -15,000 | $17.61 | 07/10/2026 | 07/13/2026 |
| Mazzariello Gina | SELL | -15,000 | $18.32 | 07/09/2026 | 07/13/2026 |
| FONTEYNE PAUL R. | BUY | +24,372 | $14.31 | 06/04/2026 | 06/08/2026 |
| MILNE GEORGE M JR | BUY | +24,372 | $14.31 | 06/04/2026 | 06/08/2026 |
| Quimi Daphne | BUY | +24,372 | $14.31 | 06/04/2026 | 06/08/2026 |
| Firestone Karen | BUY | +24,372 | $14.31 | 06/04/2026 | 06/08/2026 |
| Zeiher Bernhardt G | BUY | +24,372 | $14.31 | 06/04/2026 | 06/08/2026 |
| Firestone Karen | BUY | +3,800 | $13.51 | 05/21/2026 | 05/26/2026 |
| Bedrosian Camille L | BUY | +143,985 | $14.10 | 03/05/2026 | 03/09/2026 |
| Bedrosian Camille L | BUY | +95,990 | Not reported | 03/05/2026 | 03/09/2026 |
| Klee Justin B. | BUY | +373,295 | $14.10 | 03/05/2026 | 03/09/2026 |
| Klee Justin B. | BUY | +248,865 | Not reported | 03/05/2026 | 03/09/2026 |
| FRATES JAMES M | BUY | +143,985 | $14.10 | 03/05/2026 | 03/09/2026 |
| FRATES JAMES M | BUY | +95,990 | Not reported | 03/05/2026 | 03/09/2026 |
| Mazzariello Gina | BUY | +111,990 | $14.10 | 03/05/2026 | 03/09/2026 |
| Mazzariello Gina | BUY | +74,660 | Not reported | 03/05/2026 | 03/09/2026 |
| Cohen Joshua B | BUY | +373,295 | $14.10 | 03/05/2026 | 03/09/2026 |
| Cohen Joshua B | BUY | +248,865 | Not reported | 03/05/2026 | 03/09/2026 |
| Mazzariello Gina | SELL | -6,844 | $14.52 | 03/02/2026 | 03/04/2026 |
| FRATES JAMES M | SELL | -7,909 | $14.52 | 03/02/2026 | 03/04/2026 |